Patient Leaflet Updated 16-Dec-2025 | Neon Healthcare Ltd
Cymevene 500 mg powder for concentrate for solution for infusion
Cymevene 500 mg powder for concentrate for solution for infusion
ganciclovir
1. What Cymevene is and what it is used for
2. What you need to know before you use Cymevene
3. How to use Cymevene
4. Possible side effects
5. How to store Cymevene
6. Contents of the pack and other information
Cymevene contains the active substance ganciclovir. This belongs to a group called antiviral medicines.
Cymevene is used to treat diseases caused by a virus called cytomegalovirus (CMV) in adults and adolescent patients 12 years and older who have a weak immune system. It is also used to prevent CMV infection after an organ transplant or during chemotherapy in adults and children from birth.
Do not use Cymevene if any of the above apply to you. If you are not sure, talk to your doctor, pharmacist or nurse before using Cymevene.
Talk to your doctor, pharmacist or nurse before using Cymevene if:
If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before using Cymevene.
Look out for side effects
Cymevene can cause some serious side effects that you need to tell your doctor about straight away. Look out for the serious side effects listed in Section 4 and tell your doctor if you notice any of these while you are taking Cymevene - your doctor may tell you to stop taking Cymevene and you may need urgent medical treatment.
Tests and checks
While you are using Cymevene your doctor will do regular blood tests. This is to check the dose you are having is right for you. For the first 2 weeks these blood tests will be done often. After that the tests will be done less often.
There is limited information on how safe or effective Cymevene is as a treatment for CMV disease in children under 12 years. Babies and infants given Cymevene for prevention of CMV disease, will undergo regular blood tests.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before using Cymevene.
Pregnancy
Cymevene should not be used by pregnant women unless the benefits to the mother outweigh the possible risks to the unborn baby.
If you are pregnant or think you might be pregnant, do not use this medicine unless your doctor tells you to. This is because Cymevene may harm the unborn baby.
Contraception
You should not become pregnant while using this medicine. This is because it may affect the unborn baby.
Women
If you are a woman who could get pregnant – use contraception while you are using Cymevene.
Also do this for at least 30 days after Cymevene has been stopped.
Men
If you are a man whose female partner could get pregnant – use a barrier method of contraception (such as condoms) while you are using Cymevene. Also do this for at least 90 days after Cymevene has been stopped.
If you or your partner becomes pregnant while using Cymevene, talk to your doctor straight away.
Breastfeeding
Do not use Cymevene if you are breastfeeding. If your doctor wants you to start using Cymevene you must stop breastfeeding before you start using the medicine. This is because Cymevene may pass into breast milk.
Fertility
Cymevene may affect fertility. Cymevene may temporarily or permanently stop men from producing sperm. If you are planning to have a baby, talk to your doctor or pharmacist before using Cymevene.
You may feel sleepy, dizzy, confused or shaky, or you may lose your balance or have fits while using Cymevene. If this happens, do not drive or use any tools or machines.
This medicine contains 43 mg sodium (main component of cooking/table salt) in each 500 mg vial.
This is equivalent to 2% of the recommended maximum daily dietary intake of sodium for an adult.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Using this medicine
Cymevene will be given to you by a doctor or nurse. It will be given through a tube into your vein.
This is called an intravenous infusion and it will usually take one hour.
The dose of Cymevene varies from one patient to another. Your doctor will work out how much you need. It will depend on:
How often you will have Cymevene and how long you keep using it will also vary.
People with kidney or blood problems
If you have any kidney or blood problems your doctor might suggest a smaller dose of Cymevene and check your blood cell counts more often during treatment.
If you think you have been given too much Cymevene talk to your doctor or go to hospital straight away. You may get the following symptoms if you have too much:
Do not stop using Cymevene without talking to your doctor.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Tell your doctor straight away if you notice any of the following serious side effects – your doctor may tell you to stop taking Cymevene and you may need urgent medical treatment:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Tell your doctor straight away if you notice any of the side effects above.
Tell your doctor, pharmacist or nurse if you notice any of the following side effects:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Low blood cell counts are more likely in children, especially babies and infants.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Keep this medicine out of the sight and reach of children.
Powder: Does not require any special storage conditions. It should not be used after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
After reconstitution:
Chemical and physical in-use stability has been demonstrated for the reconstituted product for 12 hours at 25°C after dissolving with water for injections. Do not refrigerate or freeze.
From a microbiological point of view, the reconstituted solution should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.
After dilution in infusion solutions (sodium chloride 0.9%, dextrose 5%, Ringer’s or lactated Ringer’s solution for injection):
Chemical and physical in-use stability has been demonstrated for 24 hours at 2–8°C (do not freeze). From a microbiological point of view, the Cymevene infusion solution should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2°C to 8°C, unless reconstitution and dilution have taken place in controlled and validated aseptic conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Cymevene is a white to off white powder for concentrate for solution for infusion, supplied in a single-dose glass vial, with a rubber stopper and aluminium closure with flip-off cap. Reconstituted solutions of Cymevene range in colour from colourless to light yellow.
Vials of Cymevene are supplied in packs of 1 or 5. Not all pack sizes may be marketed.
or
This leaflet was last revised in December 2025.
Other sources of information
Detailed information on this medicine is available on the Medicines and Healthcare Products Regulatory Agency (MHRA) website: http://www.mhra.gov.uk
8 The Chase, John Tate Road, Foxholes Business Park, Hertford, Hertfordshire, SG13 7NN, UK
+44 (0)1992 926 330
http://www.neonhealthcare.com
+44 (0)1992 926 330
+44 (0)1992 926 330
+44 (0)1992 926 330